Chen Zhaogen,Chen Zhaogen,Cohen Michael Philip,Cohen Michael Philip,Fisher Matthew Joseph,Fisher Matthew Joseph,Gillig James Ronald,Gillig James Ronald,McCowan Jefferson Ray,McCowan Jefferson Ray,Mill
申请号：
SI200231068
公开号：
SI1859798T1
申请日:
2002.03.15
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention provides compounds of formula I pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are antagonists of the 5-HT6 receptor. The present invention further provides a method of treating disorders associated with 5-HT6 receptors, including schizophrenia, anxiety, Alzheimers disease, and cognitive disorders selected from the group consisting of age-related cognitive decline, mild cognitive impairment, and dementia, comprising: administering to a patient in need thereof an effective amount of a compound of formula I.
